Metastatic and localized breast cancer patients treated with Doxorubicin among chemotherapeutic protocol.
Measurable disease.
Age of 18 years to 80 years.
The women of childbearing age must use an effective contraception for the duration of the study.
You may not be if
Breast cancer patients who had undergone radiotherapy or chemotherapy.
Pregnant and lactating females.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to chemotherapeutic agents used.
Any other medical or psychiatric condition or severe or chronic laboratory abnormality making the inclusion of the patient in the study inappropriate in the opinion of the investigator.
Clareo Health | Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
